NanoViricides Inc. (NNVC)

[robi-1-kenobi]

For the most part, I feel the same Grover. I also lightened my load - even more so - into the R2K institutional and fund buying. But there are a couple of potential bright spots here.

First potential positive, the company reported in the 10K that they have resumed the CRADA MTA with USAMRID. They also reported they are manufacturing the needed small quantities of EbolaCide2 candidates and finalizing contracts for the initial in vitro testing. This gives them a shot on goal that if successful would generate its own momentum with funding for further testing. This could accelerate development and raise the profile of the company given the ongoing epidemic and likely long timeframe for resolution.

A successful EbolaCide2 potential outcome is uncertain, but if it plays out, we will never see lower share prices again. On the other hand, if it doesn't happen, the SP path is likely a fits and starts continuous bleed lower - as you expect - due to the now communicated longer timelines to clinical trials for FluCide.

Second potential positive, in terms of capital raise and dilution, I don't think we will see this until IND approval or more likely Australian CTx approval to begin Phase I/IIa testing in which case the promise of starting clinical trials will offset the dilution of the capital raise.

I hope the 10K is a new leaf for better executive communication, project management and execution. We will see.